With the truth that rages within me
With a thousand habits
I go out again to scatter the words
Between reality and madness, it’s all coming back to me
The place from whence I came has no peace
And this journey is heavy and a little too much for me
I need to grow through it and that’s it
To grow through it and that’s it
I live between the sacred and the profane
Between the truth that rages within me
With a thousand habits
I go out again to scatter the words
Between reality and madness, it’s all coming back to me
Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement
Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement
Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need
Concurrent PIPE financing to be used to fund clinical trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare-focused investors OrbiMed and Peter Thiel
CAMBRIDGE, Mass. and TEL-AVIV, Israel, Dec. 15, 2020 Anchiano Therapeutics Ltd. (“Anchiano”) (Nasdaq: ANCN), a preclinical biopharmaceutical company, and Chemomab Ltd. (“Chemomab”), a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, announce their entry into a definitive merger agreement pursuant to which the shareholders of Chemomab wou